• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力与感染性疾病。

Myasthenia gravis and infectious disease.

机构信息

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway.

出版信息

J Neurol. 2018 Jun;265(6):1251-1258. doi: 10.1007/s00415-018-8751-9. Epub 2018 Jan 25.

DOI:10.1007/s00415-018-8751-9
PMID:29372387
Abstract

BACKGROUND AND PURPOSE

Myasthenia gravis (MG) is an autoimmune disease with muscular weakness as the only symptom, and often with immunosuppressive treatment. All these aspects could have relevance for the risk of infections as well as their prophylactic and curative treatment.

METHODS

This is a review article, where Web of Science has been searched for relevant key words and key word combinations. Full papers were selected first by title and then by abstract.

RESULTS AND CONCLUSIONS

MG can be triggered and worsened by infections. No virus or other pathogen has been proven to have a specific link to MG. Treatment with immunosuppressive drugs and thymectomy implies a slightly increased risk for infections. Infections should be actively treated, but a few antibiotics are avoided due to potential interference with neuromuscular transmission. Hospitalization and intensive care may be necessary during infections because of MG deterioration and risk of insufficient respiration. Vaccinations are generally recommended in MG, but live microorganisms should be avoided if possible in immunosuppressed patients.

摘要

背景与目的

重症肌无力(MG)是一种以肌肉无力为唯一症状的自身免疫性疾病,常采用免疫抑制治疗。所有这些方面都可能与感染风险以及感染的预防和治疗相关。

方法

这是一篇综述文章,在 Web of Science 上检索了相关的关键词和关键词组合。首先根据标题选择全文,然后根据摘要进行选择。

结果与结论

MG 可由感染引发或加重。没有病毒或其他病原体被证明与 MG 有特定的联系。免疫抑制药物治疗和胸腺切除术会略微增加感染的风险。应积极治疗感染,但由于可能干扰神经肌肉传递,应避免使用一些抗生素。由于 MG 恶化和呼吸不足的风险,感染期间可能需要住院和重症监护。MG 患者一般建议接种疫苗,但如果可能的话,应避免免疫抑制患者使用活微生物。

相似文献

1
Myasthenia gravis and infectious disease.重症肌无力与感染性疾病。
J Neurol. 2018 Jun;265(6):1251-1258. doi: 10.1007/s00415-018-8751-9. Epub 2018 Jan 25.
2
[Therapeutic strategy in myasthenia gravis].[重症肌无力的治疗策略]
Rev Neurol (Paris). 2009 Feb;165(2):149-54. doi: 10.1016/j.neurol.2009.01.005.
3
Maintenance immunosuppression in myasthenia gravis.重症肌无力的维持性免疫抑制治疗
J Neurol Sci. 2016 Oct 15;369:294-302. doi: 10.1016/j.jns.2016.08.057. Epub 2016 Aug 28.
4
Myasthenia and the neuromuscular junction.重症肌无力与神经肌肉接头
Curr Opin Neurol. 2012 Oct;25(5):523-9. doi: 10.1097/WCO.0b013e3283572588.
5
[Myasthenia gravis: an autoimmune theory].重症肌无力:一种自身免疫理论
Nihon Rinsho. 1973 Dec;31(12):3387-93.
6
Autoimmune myasthenia gravis.自身免疫性重症肌无力
Expert Rev Neurother. 2009 Mar;9(3):351-8. doi: 10.1586/14737175.9.3.351.
7
Myasthenia gravis and autoimmunity.重症肌无力与自身免疫
Adv Intern Med. 1980;26:489-510.
8
Thymoma, myasthenia gravis, and other paraneoplastic syndromes.胸腺瘤、重症肌无力及其他副肿瘤综合征。
Hematol Oncol Clin North Am. 2008 Jun;22(3):509-26. doi: 10.1016/j.hoc.2008.03.004.
9
[Autoimmune aspects of myasthenia gravis].[重症肌无力的自身免疫方面]
Rev Hosp Clin Fac Med Sao Paulo. 1970 May-Jun;25(3):181-8.
10
Insights in the autoimmunity of myasthenia gravis.重症肌无力自身免疫的见解。
Autoimmunity. 2010 Aug;43(5-6):341-3. doi: 10.3109/08916931003592307.

引用本文的文献

1
The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care Unit.神经重症监护病房中伴有院内死亡的重症肌无力病因分析
Neurocrit Care. 2025 Aug 28. doi: 10.1007/s12028-025-02352-8.
2
Case Report: Eculizumab in highly active myasthenia gravis complicated by severe infections.病例报告:依库珠单抗治疗重症肌无力高度活跃伴严重感染
Front Immunol. 2025 Jul 31;16:1596283. doi: 10.3389/fimmu.2025.1596283. eCollection 2025.
3
Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis.

本文引用的文献

1
Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.带状疱疹疫苗加强针在美对当前已接种人群的成本效益分析
Am J Prev Med. 2017 Dec;53(6):829-836. doi: 10.1016/j.amepre.2017.08.029.
2
A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su.候选带状疱疹疫苗 HZ/su 的随机批对批免疫原性一致性研究。
Vaccine. 2017 Dec 4;35(48 Pt B):6700-6706. doi: 10.1016/j.vaccine.2017.10.017. Epub 2017 Oct 24.
3
Eculizumab: a treatment option for myasthenia gravis?依库珠单抗:重症肌无力的一种治疗选择?
在全身型重症肌无力患者中,长期使用齐卢可普兰治疗时皮质类固醇和非甾体类免疫抑制疗法的变化。
J Neurol. 2025 Jun 12;272(7):457. doi: 10.1007/s00415-025-13113-0.
4
Complications of Long COVID: Unraveling a Case of Very-Late-Onset Myasthenia Gravis.长期新冠的并发症:解析一例迟发性重症肌无力病例
Cureus. 2024 Sep 30;16(9):e70552. doi: 10.7759/cureus.70552. eCollection 2024 Sep.
5
Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long COVID.了解新型冠状病毒感染后的自身免疫反应以及长期新冠的发病机制。
Med Rev (2021). 2024 May 27;4(5):367-383. doi: 10.1515/mr-2024-0013. eCollection 2024 Oct.
6
The Risk of Exacerbation of Myasthenia Gravis After COVID-19 Omicron Infection.新冠病毒奥密克戎感染后重症肌无力恶化的风险。
Brain Behav. 2024 Oct;14(10):e70074. doi: 10.1002/brb3.70074.
7
Evaluation of Clinical Effects of COVID-19 Infection and Vaccines on Myasthenia Gravis.新型冠状病毒肺炎感染及疫苗对重症肌无力临床影响的评估
Noro Psikiyatr Ars. 2024 Aug 19;67(3):213-220. doi: 10.29399/npa.28418. eCollection 2024.
8
Clinical features of COVID-19 infection in patients with myasthenia gravis: a real-world retrospective study.新冠病毒感染合并重症肌无力患者的临床特征:一项真实世界的回顾性研究。
Front Public Health. 2024 Aug 27;12:1421211. doi: 10.3389/fpubh.2024.1421211. eCollection 2024.
9
Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis.重症肌无力与2019冠状病毒病:一项系统评价与荟萃分析
Basic Clin Neurosci. 2024 Mar-Apr;15(2):175-184. doi: 10.32598/bcn.2023.4360.5. Epub 2024 Mar 1.
10
Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.重症肌无力患者回顾性队列中与COVID-19相关的不良预后预测因素
J Inflamm Res. 2024 Aug 29;17:5807-5820. doi: 10.2147/JIR.S475729. eCollection 2024.
Lancet Neurol. 2017 Dec;16(12):947-948. doi: 10.1016/S1474-4422(17)30363-0. Epub 2017 Oct 20.
4
The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis.流感感染和疫苗接种对重症肌无力加重的影响。
J Clin Neurol. 2017 Oct;13(4):325-330. doi: 10.3988/jcn.2017.13.4.325.
5
Update From the Advisory Committee on Immunization Practices.免疫实践咨询委员会更新信息。
J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):311-316. doi: 10.1093/jpids/pix066.
6
A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis.一项关于重症肌无力患者破伤风疫苗再接种的体液免疫应答和安全性的前瞻性、安慰剂对照研究。
Vaccine. 2017 Nov 1;35(46):6290-6296. doi: 10.1016/j.vaccine.2017.09.078. Epub 2017 Oct 6.
7
Autoimmunity in narcolepsy.发作性睡病中的自身免疫
Curr Opin Pulm Med. 2017 Nov;23(6):522-529. doi: 10.1097/MCP.0000000000000426.
8
Screening, prophylaxis and counselling before the start of biological therapies: A practical approach focused on IBD patients.生物治疗前的筛查、预防和咨询:以 IBD 患者为重点的实用方法。
Dig Liver Dis. 2017 Dec;49(12):1289-1297. doi: 10.1016/j.dld.2017.09.002. Epub 2017 Sep 12.
9
Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis.类风湿关节炎患者因感染、心血管疾病、骨折和恶性肿瘤而综合住院的发生率。
Rheumatol Int. 2017 Nov;37(11):1871-1878. doi: 10.1007/s00296-017-3811-5. Epub 2017 Sep 7.
10
Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.丹麦带状疱疹疫苗接种前的流行病学:发病率及风险因素的量化分析
Vaccine. 2017 Oct 9;35(42):5589-5596. doi: 10.1016/j.vaccine.2017.08.065. Epub 2017 Sep 2.